Prognostic Value of IPF/PPF/non-PPF Classification Beyond ILD-GAP Stage in Fibrotic ILD

Abstract Background Progressive pulmonary fibrosis (PPF) identifies patients with fibrotic interstitial lung disease (F-ILD) who show progressive disease behaviour resembling idiopathic pulmonary fibrosis (IPF). However, it remains uncertain whether classification as IPF, PPF, or non-PPF provides prognostic information beyond established baseline mortality predictors. We compared the prognostic performance of IPF/PPF/non-PPF classification with the interstitial lung disease–gender–age–physiology (ILD-GAP) stage and assessed whether IPF/PPF/non-PPF classification provided additional prognostic information. Methods This is a nationwide prospective cohort study of incident F-ILD patients diagnosed at all Danish tertiary ILD centres between 1 June 2016 and 31 May 2017. Patients with fewer than two pulmonary function tests or without registry linkage were excluded. Patients were retrospectively classified as IPF, PPF, or non-PPF according to the 2022 PPF criteria. Baseline ILD-GAP stage was calculated at diagnosis. Cox proportional hazards models were used to assess all-cause mortality, and Harrell’s C-index, time-dependent area under the receiver operating characteristic curve (AUC), and Akaike’s Information Criterion (AIC) were used to compare discrimination and relative model fit. Results Among 393 incident F-ILD patients, 362 were included: 165 with IPF, 113 developed PPF, and 84 were classified as non-PPF. During follow-up, 216 patients died. In unadjusted analysis, PPF and non-PPF were associated with lower mortality hazard than IPF (HR 0.7 and 0.68; p = 0.028 and 0.035); however, these associations attenuated after adjustment for ILD-GAP stage (HR 0.93 and 0.93; p = 0.64 and 0.69). ILD-GAP stage II–III remained strongly associated with mortality in the adjusted model (HR 2.60, 95% CI 1.95–3.47; p < 0.001). Harrell’s C-index was 0.54 for IPF/PPF/non-PPF classification, 0.62 for ILD-GAP stage, and 0.62 for the combined ILD-GAP and IPF/PPF/non-PPF classification model. Pairwise comparisons of Harrell’s C-index showed ILD-GAP stage discriminated mortality risk significantly better than IPF/PPF/non-PPF classification, with an absolute increase in C-index of 0.085 (95% CI 0.042 to 0.127; p < 0.001). Adding IPF/PPF/non-PPF classification to ILD-GAP stage did not improve discrimination (difference 0.001) Conclusions After adjustment for ILD-GAP stage, the IPF/PPF/non-PPF classification did not confer prognostic value. Higher ILD-GAP was strongly associated with increased mortality, and adding IPF/PPF/non-PPF classification to ILD-GAP did not improve discrimination.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11385674/v1
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Prognostic Value of IPF/PPF/non-PPF Classification Beyond ILD-GAP Stage in Fibrotic ILD

Elisabeth M. Bendstrup, Anders Løkke, Thomas Skovhus Prior, Line Kølner-Augustson et al.
Research Square
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
preprint

Prognostic Value of IPF/PPF/non-PPF Classification Beyond ILD-GAP Stage in Fibrotic ILD

Elisabeth M. Bendstrup, Anders Løkke, Thomas Skovhus Prior, Line Kølner-Augustson, Jesper Rømhild Davidsen, Ole Hilberg, Malene Knarborg, Saher Burhan Shaker, Nanna Makholm
preprint en

Abstract

Abstract Background Progressive pulmonary fibrosis (PPF) identifies patients with fibrotic interstitial lung disease (F-ILD) who show progressive disease behaviour resembling idiopathic pulmonary fibrosis (IPF). However, it remains uncertain whether classification as IPF, PPF, or non-PPF provides prognostic information beyond established baseline mortality predictors. We compared the prognostic performance of IPF/PPF/non-PPF classification with the interstitial lung disease–gender–age–physiology (ILD-GAP) stage and assessed whether IPF/PPF/non-PPF classification provided additional prognostic information. Methods This is a nationwide prospective cohort study of incident F-ILD patients diagnosed at all Danish tertiary ILD centres between 1 June 2016 and 31 May 2017. Patients with fewer than two pulmonary function tests or without registry linkage were excluded. Patients were retrospectively classified as IPF, PPF, or non-PPF according to the 2022 PPF criteria. Baseline ILD-GAP stage was calculated at diagnosis. Cox proportional hazards models were used to assess all-cause mortality, and Harrell’s C-index, time-dependent area under the receiver operating characteristic curve (AUC), and Akaike’s Information Criterion (AIC) were used to compare discrimination and relative model fit. Results Among 393 incident F-ILD patients, 362 were included: 165 with IPF, 113 developed PPF, and 84 were classified as non-PPF. During follow-up, 216 patients died. In unadjusted analysis, PPF and non-PPF were associated with lower mortality hazard than IPF (HR 0.7 and 0.68; p = 0.028 and 0.035); however, these associations attenuated after adjustment for ILD-GAP stage (HR 0.93 and 0.93; p = 0.64 and 0.69). ILD-GAP stage II–III remained strongly associated with mortality in the adjusted model (HR 2.60, 95% CI 1.95–3.47; p < 0.001). Harrell’s C-index was 0.54 for IPF/PPF/non-PPF classification, 0.62 for ILD-GAP stage, and 0.62 for the combined ILD-GAP and IPF/PPF/non-PPF classification model. Pairwise comparisons of Harrell’s C-index showed ILD-GAP stage discriminated mortality risk significantly better than IPF/PPF/non-PPF classification, with an absolute increase in C-index of 0.085 (95% CI 0.042 to 0.127; p < 0.001). Adding IPF/PPF/non-PPF classification to ILD-GAP stage did not improve discrimination (difference 0.001) Conclusions After adjustment for ILD-GAP stage, the IPF/PPF/non-PPF classification did not confer prognostic value. Higher ILD-GAP was strongly associated with increased mortality, and adding IPF/PPF/non-PPF classification to ILD-GAP did not improve discrimination.

Research Square
Aalborg University Hospital (DK), Odense University Hospital (DK), Aarhus University Hospital (DK), Gentofte Hospital (DK), Lillebaelt Hospital (DK)
Good health and well-being
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon